ASCENDIS PHARMA A S's ticker is and the CUSIP is 04351P901. A total of 3 filers reported holding ASCENDIS PHARMA A S in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $613,710 | -13.6% | 4,500 | -4.3% | 0.00% | – |
| Q1 2024 | $710,499 | +108.9% | 4,700 | +74.1% | 0.00% | – |
| Q4 2023 | $340,065 | -85.4% | 2,700 | -89.1% | 0.00% | -100.0% |
| Q3 2023 | $2,322,272 | -37.9% | 24,800 | -40.8% | 0.00% | 0.0% |
| Q2 2023 | $3,739,575 | -14.3% | 41,900 | +2.9% | 0.00% | -50.0% |
| Q1 2023 | $4,363,854 | -78.5% | 40,700 | -75.5% | 0.00% | -77.8% |
| Q4 2022 | $20,298,006 | +22.9% | 166,200 | +3.9% | 0.01% | +28.6% |
| Q3 2022 | $16,511,000 | +174.5% | 159,900 | +147.1% | 0.01% | +133.3% |
| Q2 2022 | $6,015,000 | – | 64,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 50 | $834,000 | 0.03% |
| JPMORGAN CHASE & CO | 27,000 | $4,503,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 19 | $316,000 | 0.00% |